Fortress Biotech (FBIO) Analyst & Key Data

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

6

Ratings

Updated Sep 12, 2026

Overall Rating

A-

DCF Score1.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$2.52

Median Target+98.41%

$5.00

Potential upside vs current price

DCF Value-130.12%

-$0.76

Potential downside vs current price

Current Stock Price

$2.52

Median Target+98.41%

$5.00

Potential upside vs current price

DCF Value-130.12%

-$0.76

Potential downside vs current price

Analyst Consensus

Buy1 analysts

Buy

Updated Sep 12, 2026

Total Analysts1

Buy

6

Ratings

Updated Sep 12, 2026

Overall Rating

A-

DCF Score1.0 / 5

Debt / Equity Score2.0 / 5

Price / Book Score5.0 / 5

Price / Earnings Score3.0 / 5

ROA Score5.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$2.52

Median Target+98.41%

$5.00

Potential upside vs current price

DCF Value-130.12%

-$0.76

Potential downside vs current price

Current Stock Price

$2.52

Median Target+98.41%

$5.00

Potential upside vs current price

DCF Value-130.12%

-$0.76

Potential downside vs current price

Fortress Biotech, Inc.